BioCentury
ARTICLE | Company News

Cambridge Centre for Protein Engineering other research news

November 3, 1997 8:00 AM UTC

Cambridge Centre scientists and colleagues published in Nature Biotechnology the use of antibody fragments against the oncofetal isoform of fibronectin (B- FN) to image cancer in vivo. B-FN is an extracellular matrix protein expressed in cancer tissue during tumor angiogenesis but not in mature blood vessels. The antibodies were used to image solid teratocarcinoma tumors grafted into mice. ...